Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Quipt Home Medical Corp (QIPT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.98 -0.03    -0.60%
26/04 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 9,325
  • Bid/Ask: 4.98 / 5.00
  • Day's Range: 4.95 - 5.05
Quipt Home Medical 4.98 -0.03 -0.60%

QIPT Recent Sentiments

 
This page contains information on users’ sentiments for the Quipt Home Medical Corp stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 23, 2023 Stanley CC   8.40 Feb 17, 2023 @ 8.30 -1.19%
Jul 20, 2022 Fernando Cabaleiro   6.71 Aug 13, 2022 @ 6.93 +3.28%
Nov 17, 2021 kate L   8.41 Dec 10, 2021 @ 7.38 +12.25%
Oct 20, 2021 aInc   6.99 Nov 12, 2021 @ 7.54 +7.87%
Sep 20, 2021 Richard Bowers   7.27 Oct 15, 2021 @ 7.30 +0.41%
Sep 07, 2021 Paul Eales   8.10 Oct 01, 2021 @ 7.86 -2.96%
Aug 24, 2021 Richard Bowers   8.10 Sep 17, 2021 @ 7.33 -9.51%
May 25, 2021 aInc   8.42 May 31, 2021 @ 8.45 +0.36%
May 03, 2021 kate L   2.04 May 12, 2021 @ 2.11 -3.43%
Jan 13, 2021 Payton Davey   1.91 Feb 05, 2021 @ 2.20 +15.18%
Jan 13, 2021 aInc   2.00 Feb 05, 2021 @ 2.20 +10.00%
Dec 23, 2020 Jessy Trottier   1.68 Jan 15, 2021 @ 1.92 +14.29%
Dec 01, 2020 Payton Davey   1.58 Dec 25, 2020 @ 1.63 +3.16%
Nov 24, 2020 Richard Bowers   1.49 Dec 18, 2020 @ 1.47 -1.34%
Oct 16, 2020 aInc   1.52 Nov 06, 2020 @ 1.72 +13.16%
Oct 05, 2020 Richard Bowers   1.30 Oct 30, 2020 @ 1.63 +25.38%
Sep 25, 2020 rick wan   1.28 Oct 16, 2020 @ 1.50 +17.19%
Sep 10, 2020 aInc   1.43 Oct 02, 2020 @ 1.30 -9.09%
Jul 17, 2020 Mohamad Ghazaoui   1.20 Aug 07, 2020 @ 1.11 -7.50%
Jul 07, 2020 Chad Glascock   1.15 Jul 31, 2020 @ 1.11 -3.48%
Jun 10, 2020 Robin Forst   1.22 Jul 03, 2020 @ 1.15 -5.74%
Jun 05, 2020 aInc   1.17 Jun 26, 2020 @ 1.12 +4.27%
Jun 01, 2020 Kim Shaheen   1.28 Jun 26, 2020 @ 1.12 -12.50%
Jun 01, 2020 mohammad shahmirza   1.33 Jun 26, 2020 @ 1.12 -15.79%
Jun 01, 2020 Dwayne Ten   1.34 Jun 26, 2020 @ 1.12 -16.42%
May 19, 2020 Alireza Samea   1.04 May 21, 2020 @ 1.07 +2.88%
May 12, 2020 mohammad tavana   1.12 Jun 05, 2020 @ 1.18 +5.36%
May 06, 2020 Stéphane Bouffard   0.99 May 29, 2020 @ 1.29 +30.30%
Apr 16, 2020 Richard Bowers   0.82 May 08, 2020 @ 0.99 +20.73%
Feb 19, 2020 Kalyn Bedford   0.90 Mar 13, 2020 @ 0.57 -36.67%
Oct 02, 2019 Francis Gauthier   0.80 Oct 25, 2019 @ 0.98 +22.50%
Jul 19, 2019 Marc Gratton   0.76 Aug 09, 2019 @ 0.79 -3.95%
Jun 25, 2019 Yang Wang   0.73 Jul 19, 2019 @ 0.74 -1.37%
May 22, 2019 Jeremie Perron   0.84 Jun 14, 2019 @ 0.77 +8.33%
May 09, 2019 Simin Situ   0.86 May 31, 2019 @ 0.73 +15.12%
Apr 12, 2019 Marco Bouchard   0.98 May 03, 2019 @ 0.99 +1.02%
Feb 01, 2019 Ray Broughton   0.97 Mar 03, 2019 @ 0.91 -6.19%
Jan 31, 2019 Dave Howe   1.03 Mar 02, 2019 @ 0.91 -11.65%
Jan 29, 2019 Camille Dagenais   0.87 Feb 28, 2019 @ 0.89 +2.30%
Jan 22, 2019 Jp Lacroix   0.72 Feb 22, 2019 @ 0.43 -40.28%
Dec 14, 2018 Jp Lacroix   0.68 Jan 13, 2019 @ 0.43 -36.76%
Sep 27, 2018 Julien Godon...   0.17 Oct 27, 2018 @ 0.43 +152.94%
Aug 27, 2018 Jessy Trottier   0.13 Sep 26, 2018 @ 0.17 +30.77%
May 24, 2018 David Plante   0.14 Jun 23, 2018 @ 0.13 -10.34%
May 23, 2018 Savio   0.13 Jun 22, 2018 @ 0.13 0.00%
May 15, 2018 Christian Soucy   0.10 Jun 14, 2018 @ 0.14 -42.11%
Jan 17, 2018 Maureen Coleman   0.15 Feb 16, 2018 @ 0.11 -26.67%
Jun 13, 2017 Maxime Ross   0.49 Jul 13, 2017 @ 0.39 -20.41%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

QIPT Comments

Write your thoughts about Quipt Home Medical Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
mitch denman
mitch denman May 28, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they talked about it on Bloomberg yesterday, hopefully gives it a boost
My Watch
My Watch Mar 12, 2018 6:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought at 10 cents will hold till .19 cents
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email